Dr Wasat Mansoor and Professor Denis Talbot invite you to contribute to the LEAP Study.
What is the LEAP Study?
This important study aims to provide a better understanding of the current epidemiology and management of Lung Neuroendocrine Tumours within the UK. It is being run as a nationwide survey, is endorsed by UKINETS, and funded by Novartis Oncology.
What will it show us?
The survey aims to find out more about the current Lung NET patient pathway. We anticipate that once published, this information will help to streamline Lung NET services across the UK, and also identify areas of unmet need.
How can I help?
If you are involved in the triage or management of Lung NET patients, or have a colleague who is, we would really like to hear from you. Please contact one of the team who can provide further information on next steps:
NovartisMedicalContact: StuartFerguson: email@example.com
NHS Contacts: Dr. Wasat Mansoor (Christie Hospitals NHS Trust): firstname.lastname@example.org Prof.Denis Talbot (Oxford NHS Trust): email@example.com
ONC17-E008, Jan 2017